Jennifer Bell, founding partner, provides political context for and strategic insights into “The Biden Administration, the 117 Congress, and What We Might See in Healthcare.”
Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!
In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continue their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition. They also discuss the important issue of prescription drug pricing reform and how we can anticipate the Biden Administration and Congress may deal with the issue.
A&M’s Healthcare Industry Group Co-Head, Peter Urbanowicz, is joined by Dr. David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs and Jennifer Bell, Founding Partner of Chamber Hill Strategies, as they discuss and share perspectives on what the Healthcare landscape and future look like under the Biden Administration.
In part one, Dr. Shulkin and Ms. Bell discuss the role of the cabinet secretary and how the White House and cabinet agencies shape healthcare policy. They also discuss the latest $1.9 trillion COVID-19 stimulus bill and how the bill will affect the ACA Exchanges and Medicaid. And, with Democrats holding the Presidency and both Houses of Congress right now, our experts also weigh in on what the future of federal healthcare policy looks like over the next four years.
Jennifer Bell, founding partner, previewed what 2021 looks like for drug pricing, 340B, and oncology care at the annual meeting of the Association of Cancer Executives.
Jennifer Bell, founding partner, presented during “Women at the Helm,” a featured discussion about women going out on their own to open policy shops. The organization 131 & Counting brings together women congressional staff and women policy professionals to discuss insights into organizational diversity both on and off the Hill; the proliferation of women-owned firms and contractors; and navigate how gender matters in policy areas once mostly exclusive to men.
Jennifer Bell, founding partner, along with the oncology strategic planning team at ECG Management Consultants, discussed the evolving reimbursement environment for oncology practices and presented practical solutions in this hour-long webinar.
Jennifer Bell, founding partner, presented the outlook for legislation and regulation on prescription drug prices, health care costs, and provider payments at the esteemed annual Princeton Conference, hosted by the Heller School for Social Policy and Management at Brandeis University.
In this video, Dr. Alok Patel interviews Jennifer Bell, founding partner, on how physicians can make their voices heard with government officials. According to Bell, “The federal government has a huge role in paying and regulating healthcare. If your voice isn’t out there, you’re going to take whatever you get. The government is going to decide for you, whether they have your input or not. I’d say that 2020 is not the last time that we need your voice, but it is such a critical year.”